TransMedics Group, Inc. — Director's Dealing 2025

Aug 8, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2025-08-06

Reporting Person: Hassanein Waleed H (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-06	Common Stock	P	8400	$118.68	Acquired	477759	Indirect
2025-08-07	Common Stock	P	6617	$116.08	Acquired	484376	Indirect
2025-08-07	Common Stock	P	1858	$116.85	Acquired	486234	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	121424	Direct

Footnotes

F1: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $118.50 to $118.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $115.60 to $116.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F3: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $116.62 to $117.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.